A Neurochemical Perspective on States of Consciousness

  • Christopher J. Watson
  • Helen A. Baghdoyan
  • Ralph Lydic
Chapter
Part of the Contemporary Clinical Neuroscience book series (CCNE)

Abstract

The foundation of anesthesia rests upon discoveries made by chemists. This is illustrated by Joseph Preistly’s and Humphrey Davy’s research on nitrous oxide; Paracelsus’ work with ether; the studies of chemists Eugène Soubeiran, Justus von Liebig, Samual Gutherie, and Jean-Baptiste Dumas with chloroform; and more recently Paul Janssen’s development of fentanyl. Anesthetics are synthetic compounds that exert effects on one or more endogenous neurochemical systems to produce a behavioral state characterized by traits that include unconsciousness, amnesia, and analgesia. The mechanisms by which anesthetics cause the loss of consciousness (hypnosis) are not known, but there is compelling evidence that anesthetics alter the endogenous neurochemical systems that regulate sleep and wakefulness (Keifer et al. 1994; Lydic 1996; Vanini et al. 2008). Advances in analytical chemistry now make it possible to begin a systematic characterization of the endogenous molecules that regulate states of consciousness such as sleep and anesthesia. This chapter provides a brief overview of sleep neurobiology and its unique relevance for efforts to understand the neurochemical mechanisms of anesthesia. Readers are referred elsewhere for detailed reviews on sleep (Lydic and Biebuyck 1994; España and Scammell 2004; Steriade and McCarley 2005; Datta and MacLean 2007; McCarley 2007; Monti, Pandi-Perumal, and Sinton 2008).

Keywords

Sleep anesthesia neurochemistry acetylcholine GABA adenosine neuropeptide 

Notes

Disclosure Statement

This work supported by National Institutes of Health grants: HL40881, MH45361, HL57120, HL65272, and the Department of Anesthesiology. We thank Mary A. Norat, Giancarlo Vanini, and Sarah L. Watson for critical comments on this chapter. This work was not an industry-supported study, and the authors have no financial conflicts of interest.

References

  1. Akanmu M. A., O. E. Ukponmwan, Y. Katayama, and K. Honda. 2006. Neuropeptide-Y Y2-receptor agonist, PYY3–36 promotes non-rapid eye movement sleep in rat. Neurosci Res 54:165–170.PubMedGoogle Scholar
  2. Alam, M. N., H. Gong, T. Alam, R. Jaganath, D. J. McGinty, and R. Szymusiak. 2002. Sleep-waking discharge patterns of neurons recorded in the rat perifornical lateral hypothalamic area. J Physiol 538:619–631.PubMedGoogle Scholar
  3. Alam, M. N., R. Szymusiak, H. Gong, J. King, and D. J. McGinty. 1999. Adenosinergic modulation of rat basal forebrain neurons during sleep and waking: neuronal recording with microdialysis. J Physiol 521.3:679–690.Google Scholar
  4. Alexandre, C., A. Dordal, R. Aixendri, A. Guzman, M. Hoamon, and J. Adrien. 2008. Sleep-stabilizing effects of E-6199, compared to zopiclone, zolpidem, and THIP in mice. Sleep 31:259–270.PubMedGoogle Scholar
  5. Alkire, M. T., A. G. Hudetz, and G. Tononi. 2008. Consciousness and anesthesia. Science 322:876–880.PubMedGoogle Scholar
  6. Alkire, M. T., J. R. McReynolds, E. L. Hahn, and A. N. Trivedi. 2007. Thalamic microinjection of nicotine reverses sevoflurane-induced loss of righting reflex in the rat. Anesthesiology 107:264–272.PubMedGoogle Scholar
  7. Anderson, M. L., R. Margis, B. N. Frey, L. M. F. Giglio, F. Kapczinski, and S. Tufik. 2009. Electrophysiological correlates of sleep disturbance induced by acute and chronic administration of D-amphetamine. Brain Res 1249:162–172.Google Scholar
  8. Anderson, M. L., D. C. Nascimento, R. B. Machado, S. Roizenblatt, H. Moldofsky, and S. Tufik. 2006. Sleep disturbance induced by substance P in mice. Behav Brain Res 167:212–218.Google Scholar
  9. Aserinsky, E., and N. Kleitman. 1953. Regularly occurring periods of eye motility, and concomitant phenomena, during sleep. Science 118:273–274.PubMedGoogle Scholar
  10. Aston-Jones, G., and F. E. Bloom. 1981. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J Neurosci 1:876–886.PubMedGoogle Scholar
  11. Autret, A., F. Laffont, B. de Toffol, and H. P. Cathala. 1988. A syndrome of REM and non-REM sleep reduction and lateral gaze paresis after medial tegmental pontine stroke. Computed tomographic scans and anatomical correlations in four patients. Arch Neurol 45:1236–1242.PubMedGoogle Scholar
  12. Baars, B. J., T. Z. Ramsoy, and S. Laureys. 2003. Brain, conscious experience and the observing self. Trends Neurosci 26:671–675.PubMedGoogle Scholar
  13. Baghdoyan, H. A. 1997. Location and quantification of muscarinic receptor subtypes in rat pons: implications for REM sleep generation. Am J Physiol 273:R896–R904.PubMedGoogle Scholar
  14. Baghdoyan, H. A., B. X. Carlson, and M. T. Roth. 1994. Pharmacological characterization of muscarinic cholinergic receptors in cat pons and cortex. Preliminary study. Pharmacology 48:77–85.PubMedGoogle Scholar
  15. Baghdoyan, H. A., and R. Lydic. 1999. M2 muscarinic receptor subtype in the feline medial pontine reticular formation modulates the amount of rapid eye movement sleep. Sleep 22:835–847.PubMedGoogle Scholar
  16. Baghdoyan, H. A., R. Lydic, C. W. Callaway, and J. A. Hobson. 1989. The carbachol-induced enhancement of desynchronized sleep signs is dose dependent and antagonized by centrally administered atropine. Neuropsychopharmacol 2:67–79.Google Scholar
  17. Baghdoyan, H. A., A. Monaco, M. L. Rodrigo-Angulo, F. Assens, R. W. McCarley, and J. A. Hobson. 1984. Microinjection of neostigmine into the pontine reticular formation of cats enhances desynchronized sleep signs. J Pharmacol Exp Ther 231:173–180.PubMedGoogle Scholar
  18. Baghdoyan, H. A., M. L. Rodrigo-Angulo, R. W. McCarley, and J. A. Hobson. 1984. Site-specific enhancement and suppression of desynchronized sleep signs following cholinergic stimulation of three brain stem regions. Brain Res 306:39–52.PubMedGoogle Scholar
  19. Baghdoyan, H. A., M. L. Rodrigo-Angulo, R. W. McCarley, and J. A. Hobson. 1987. A neuroanatomical gradient in the pontine tegmentum for the cholinoceptive induction of desynchronized sleep signs. Brain Res 414:245–261.PubMedGoogle Scholar
  20. Barbier, A. J., C. Berridge, C. Dugovic, A. D. Laposky, S. J. Wilson, J. Boggs, L. Aluisio, B. Lord, C. Mazur, C. M. Pudiak, X. Langlois, W. Xiao, R. Apodaca, and N. I. Carruthers. 2004. Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist. Br J Pharmacol 143:649–661.PubMedGoogle Scholar
  21. Barbosa, R. M., C. F. Lourenço, R. M. Santos, F. Pomerleau, P. Huettl, G. A. Gerhardt, and J. Laranjinha. 2008. In vivo real-time measurement of nitric oxide in anesthetized rat brain. Methods Enzymol 441:351–367.PubMedGoogle Scholar
  22. Basheer, R., L. Halldner, L. Alanko, R. W. McCarley, B. B. Fredholm, and T. Porkka-Heiskanen. 2001. Opposite changes in adenosine A1 and A2A receptor mRNA in the rat following sleep deprivation. Neuroreport 12:1577–1580.PubMedGoogle Scholar
  23. Bayer, L., E. Eggerman, M. Serafin, B. Saint-Mleux, D. Machard, B. E. Jones, and M. Muhlethaler. 2001. Orexins (hypocretins) directly excite tuberomammillary neurons. Eur J Neurosci 14:1571–1575.PubMedGoogle Scholar
  24. Berger, H. 1929. Uber das elektroenkephalogramm des menchen. Arch Psychiatr Nervenkr 87:527–570.Google Scholar
  25. Bernard, R., R. Lydic, and H. A. Baghdoyan. 2003. Hypocretin-1 causes G protein activation and increases ACh release in rat pons. Eur J Neurosci 18:1775–1785.PubMedGoogle Scholar
  26. Bernard, R, R. Lydic, and H. A. Baghdoyan. 2006. Hypocretin (orexin) receptor subtypes differentially enhance acetylcholine release and activate G protein subtypes in rat pontine reticular formation. J Pharmacol Exp Ther 317:163–171.PubMedGoogle Scholar
  27. Berridge, C. W., and E. D. Abercrombie. 1999. Relationship between locus coeruleus discharge rates and rates of norepinephrine release within the neocortex as assessed by in vivo microdialysis. Neuroscience 93:1263–1270.PubMedGoogle Scholar
  28. Berridge, C. W., and S. L. Foote. 1996. Enhancement of behavioral and electroencephalographic indices of waking following stimulation of noradrenergic beta-receptors within the medial septal region of the basal forebrain. J Neurosci 16:6999–7009.PubMedGoogle Scholar
  29. Berridge, C. W., S. O. Isaac, and R. A. España. 2003. Additive wake-promoting actions of medial basal forebrain noradrenergic α1- and β-receptor stimulation. Behav Neurosci 117:350–359.PubMedGoogle Scholar
  30. Berridge, C. W., and B. D. Waterhouse. 2003. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Rev 42:33–84.PubMedGoogle Scholar
  31. Beuckmann, C. T., C. M. Sinton, S. C. Williams, J. A. Richardson, R. E. Hammer, T. Sakurai, and M. Yanagisawa. 2004. Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat. J Neurosci 24:4469–4477.PubMedGoogle Scholar
  32. Bingham, S., P. T. Davey, A. J. Babbs, E. A. Irving, M. J. Sammons, M. Wyles, P. Jeffrey, L. Cutler, I. Riba, A. Johns, R. A. Porter, N. Upton, A. J. Hunter, and A. A. Parsons. 2001. Orexin-A, an hypothalamic peptide with analgesic properties. Pain 92:81–90.PubMedGoogle Scholar
  33. Bischoff, P. 2006. Monitoring methods: SNAP. Best Pract Res Clin Anaesthesiol 20:141–146.PubMedGoogle Scholar
  34. Bonafide, C. P., N. Aucutt-Walter, N. Divittore, T. King, E. O. Bixler, and A. J. Cronin. 2008. Remifentanil inhibits rapid eye movement sleep but not the nocturnal melatonin surge in humans. Anesthesiology 108:627–633.PubMedGoogle Scholar
  35. Bourgin, P., P. Escourrou, C. Gaultier, and J. Adrien. 1995. Induction of rapid eye movement sleep by carbachol infusion into the pontine reticular formation in the rat. Neuroreport 6:532–536.PubMedGoogle Scholar
  36. Bourgin, P., S. Huitron-Resendiz, A. D. Spier, V. Fabre, B. Morte, J. R. Criado, J. G. Sutcliffe, S. J. Henriksen, and L. de Lecea. 2000. Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons. J Neurosci 20:7760–7765.PubMedGoogle Scholar
  37. Bouthenet, M. L., M. Ruat, N. Sales, and M. Garbarg. 1988. A detailed mapping of histamine H1-receptors in guinea-pig central nervous system established by autoradiography with [125]iodobopyramine. Neuroscience 26:553–600.PubMedGoogle Scholar
  38. Boutrel, B., B. Franc, R. Hen, M. Hamon, and J. Adrien. 1999. Key role of 5-HT1B receptors in the regulation of paradoxical sleep as evidenced in 5-HT1B knock-out mice. J Neurosci 19:3204–3212.PubMedGoogle Scholar
  39. Boutrel, B., and G. F. Koob. 2004. What keeps us awake: the neuropharmacology of stimulants and wakefulness-promoting medications. Sleep 27:1181–1194.PubMedGoogle Scholar
  40. Boutrel, B., C. Monaca, R. Hen, M. Hamon, and J. Adrien. 2002. Involvement of 5-HT1A receptors in homeostatic and stress-induced adaptive regulations of paradoxical sleep: studies in 5-HT1A knock-out mice. J Neurosci 22:4686–4692.PubMedGoogle Scholar
  41. Brisbare-Roch, C., J. Dingemanse, R. Koberstein, P. Hoever, H. Aissaoui, S. Flores, C. Mueller, O. Nayler, J. van Gervan, S. L. de Haas, P. Hess, C. Qiu, S. Buchmann, M. Scherz, T. Weller, W. Fischli, M. Clozel, and F. Jenck. 2007. Promotion of sleep by targeting the orexin system in rats, dogs, and humans. Nat Med 13:150–155.PubMedGoogle Scholar
  42. Brischoux, F., L. Mainville, and B. E. Jones. 2008. Muscarinic-2 and orexin-2 receptors on GABAergic and other neurons in the rat mesopontine tegmentum and their potential role in sleep-wake control. J Comp Neurol 510:607–630.PubMedGoogle Scholar
  43. Brown, R. E., O. Sergeeva, K. S. Eriksson, and H. L. Haas. 2001. Orexin A excites serotonergic neurons in the dorsal raphé nucleus of the rat. Neuropharmacology 40:457–459.Google Scholar
  44. Brown, R. E., O. Sergeeva, K. S. Eriksson, and H. L. Haas. 2002. Convergent excitation of dorsal raphé serotonin neurons by multiple arousal systems (orexin/hypocretin, histamine and noradrenaline). J Neurosci 22:8850–8859.PubMedGoogle Scholar
  45. Bruno, J. P., C. Gash, B. Martin, A. Zmarowski, F. Pomerleau, J. Burmeister, P. Huettl, and G. A. Gerhardt. 2006. Second-by-second measurement of acetylcholine release in prefrontal cortex. Eur J Neurosci 24:2749–2757.PubMedGoogle Scholar
  46. Burlet, S., C. J. Tyler, and C. S. Leonard. 2002. Direct and indirect excitation of laterodorsal tegmental neurons by hypocretin/orexin peptides: implications for wakefulness and narcolepsy. J Neurosci 22:2862–2872.PubMedGoogle Scholar
  47. Burmeister, J. J., K. Moxon, and G. A. Gerhardt. 2000. Ceramic-based multisite microelectrodes for electrochemical recordings. Anal Chem 72:187–192.PubMedGoogle Scholar
  48. Burmeister, J. J., F. Pomerleau, P. Huettl, C. R. Gash, C. E. Werner, J. P. Bruno, and G. A. Gerhardt. 2008. Ceramic-based multisite microelectrode arrays for simultaneous measures of choline and acetylcholine in CNS. Biosens Bioelectron 23:1382–1389.PubMedGoogle Scholar
  49. Burmeister, J. J., F. Pomerleau, M. Palmer, B. K. Day, P. Huettl, and G. A. Gerhardt. 2002. Improved ceramic-based multisite microelectrode for rapid measurements of L-glutamate in the CNS. J Neurosci Methods 119:163–171.PubMedGoogle Scholar
  50. Byford, A. J., A. Anderson, P. S. Jones, R. Palin, and A. K. Houghton. 2007. The hypnotic, electroencephalographic, and antinociceptive properties of nonpeptide ORL1 receptor agonists after intravenous injection in rodents. Anesth Analg 104:174–179.PubMedGoogle Scholar
  51. Caballero, A., and I. de Andrés. 1986. Unilateral lesions in locus coeruleus area enhance paradoxical sleep. Electroenceph Clin Neurophysiol 64:339–346.PubMedGoogle Scholar
  52. Camacho-Arroyo, I., R. Alvarado, J. Manjarrez, and R. Tapia. 1991. Microinjections of muscimol and bicuculline into the pontine reticular formation modify the sleep-waking cycle in the rat. Neurosci Lett 129:95–97.PubMedGoogle Scholar
  53. Campagna, J. A., K. W. Miller, and S. A. Forman. 2003. Mechanisms of actions of inhaled anesthetics. N Engl J Med 348:2110–2124.PubMedGoogle Scholar
  54. Capece, M. L., H. A. Baghdoyan, and R. Lydic. 1998. Carbachol stimulates [35S]guanylyl 5-(γ-thio)-triphosphate binding in rapid eye movement sleep-related brainstem nuclei of rat. J Comp Neurol 18:3779–3785.Google Scholar
  55. Caton, R. 1875. The electric currents of the brain. Br Med J 2:278.Google Scholar
  56. Cellar, N. A., S. T. Burns, J. C. Meiners, H. Chen, and R. T. Kennedy. 2005. Microfluidic chip for low-flow push–pull perfusion sampling in-vivo with on-line analysis of amino acids. Anal Chem 77:7067–7073.PubMedGoogle Scholar
  57. Chemelli, R. M., J. T. Willie, C. M. Sinton, J. K. Elmquist, T. E. Scammell, C. Lee, J. A. Richardson, S. C. Williams, Y. Xiong, Y. Kisanuki, T. E. Fitch, M. Nakazato, R. E. Hammer, C. B. Saper, and M. Yanagisawa. 1999. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98:437–451.PubMedGoogle Scholar
  58. Cheng, J.-K., R. C.-C. Chou, L.-L. Hwang, and L.-C. Chiou. 2003. Antiallodynic effects of intrathecal orexins in a rat model of postoperative pain. J Pharmacol Exp Ther 307:1065–1071.PubMedGoogle Scholar
  59. Chu, N., and F. E. Bloom. 1973. Norepinephrine-containing neurons: changes in spontaneous discharge patterns during sleeping and waking. Science 179:908–910.PubMedGoogle Scholar
  60. Chung, S. A., H. Yuan, and F. Chung. 2008. A systematic review of obstructive sleep apnea and its implications for anesthesiologists. Anesth Analg 107:1643–1663.Google Scholar
  61. Clark, S. D., H-P. Nothacker, Z. Wang, Y. Saito, F. M. Leslie, and O. Civelli. 2001. The urotensin II receptor is expressed in the cholinergic mesopontine tegmentum of the rat. Brain Res 923:120–127.PubMedGoogle Scholar
  62. Coleman, C. G., H. A. Baghdoyan, and R. Lydic. 2006. Dialysis delivery of an adenosine A2A agonist into the pontine reticular formation of C57BL/6 J mouse increases pontine acetylcholine release and sleep. J Neurochem 96:1750–1759.PubMedGoogle Scholar
  63. Coleman, C. G., R. Lydic, and H. A. Baghdoyan. 2004. M2 muscarinic receptors in pontine reticular formation of C57BL/6 J mouse contribute to rapid eye movement sleep generation. Neuroscience 126:821–830.PubMedGoogle Scholar
  64. Cooper, J. R., F. E. Bloom, and R. H. Roth. 2002. Biochemical Basis of Neuropharmacology. 8th ed. Oxford: Oxford University Press.Google Scholar
  65. Cornwall, J., J. D. Cooper, and O. T. Phillipson. 1990. Afferent and efferent connections of the laterodorsal tegmental nucleus in the rat. Brain Res Bull 25:271–284.PubMedGoogle Scholar
  66. Cronin, A., J. C. Keifer, H. A. Baghdoyan, and R. Lydic. 1995. Opioid inhibition of rapid eye movement sleep by a specific mu receptor agonist. Br J Anaesth 74:188–192.PubMedGoogle Scholar
  67. Datta, S., and R. R. MacLean. 2007. Neurobiological mechanisms for the regulation of mammalian sleep-wake behavior: reinterpretation of historical evidence and inclusion of contemporary cellular and molecular evidence. Neurosci Biobehav Rev 31:775–824.PubMedGoogle Scholar
  68. Datta, S., E. H. Patterson, and E. E. Spoley. 2001. Excitation of the pedunculopontine tegmental NMDA receptors induces wakefulness and cortical activation in the rat. J Neurosci Res 66(1):109–116.PubMedGoogle Scholar
  69. Datta, S., E. E. Spoley, V. K. Mavanji, and E. H. Patterson. 2002. A novel role of pedunculopontine tegmental kainate receptors: a mechanism of rapid eye movement sleep generation in the rat. Neuroscience 114:157–164.PubMedGoogle Scholar
  70. Datta, S., E. E. Spoley, and E. H. Patterson. 2001. Microinjection of glutamate into the pedunculopontine tegmentum induces REM sleep and wakefulness in the rat. Am J Physiol Regul Integr Comp Physiol 280:R752–R759.PubMedGoogle Scholar
  71. Day, J., G. Damsma, and H. C. Fibiger. 1991. Cholinergic activity in the rat hippocampus, cortex and striatum correlates to locomotor activity: an in vivo microdialysis study. Pharmacol Biochem Behav 38:723–729.PubMedGoogle Scholar
  72. de Lecea, L., J. R. Criado, Ó. Prospero-Garcia, K. M. Gautvik, P. Schweitzer, P. E. Danielson, C. L. M. Dunlop, G. R. Siggins, S. J. Henriksen, and J. G. Sutcliffe. 1996. A cortical neuropeptide with neuronal depressant and sleep-modulating properties. Nature 381:242–245.PubMedGoogle Scholar
  73. de Lecea, L., T. S. Kilduff, C. Peyron, X. B. Gao, P. E. Foye, P. E. Danielson, C. Fukuhara, E. L. F. Battenberg, V. T. Gautvik, F. S. Bartlett II, W. N. Frankel, A. N. van den Pol, F. E. Bloom, K. M. Gautvik, and J. G. Sutcliffe. 1998. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 95:322–327.PubMedGoogle Scholar
  74. Deboer, T., M. J. Vansteensel, L. Détári, and J. H. Meijer. 2003. Sleep states alter activity of suprachiasmatic nucleus neurons. Nat Neurosci 6:1086–1090.PubMedGoogle Scholar
  75. DeMarco, G. J., H. A. Baghdoyan, and R. Lydic. 2003. Differential cholinergic activation of G proteins in rat and mouse brainstem: relevance for sleep and nociception. J Comp Neurol 457:175–184.PubMedGoogle Scholar
  76. Dement, W. 1958. The occurrence of low voltage, fast electroencephalogram patterns during behavioral sleep in cat. Electroenceph Clin Neurophysiol 10:291–296.PubMedGoogle Scholar
  77. Dement, W., and N. Kleitman. 1957. Cyclic variations in EEG during sleep and their relation to eye movements, body motility, and dreaming. Electroenceph Clin Neurophysiol 9:673–690.PubMedGoogle Scholar
  78. Dimsdale, J. E., D. Norman, D. DeJardin, and M. S. Wallace. 2007. The effect of opioids on sleep architecture. J Clin Sleep Med 15:33–36.Google Scholar
  79. Dong, H.-L., S. Fukuda, E. Murata, Z. Zhu, and T. Higuchi. 2006. Orexins increase cortical acetylcholine release and electroencephalographic activation through orexin-1 receptor in the rat basal forebrain during isoflurane anesthesia. Anesthesiology 104:1023–1032.PubMedGoogle Scholar
  80. Douglas, C. L., G. N. Bowman, H. A. Baghdoyan, and R. Lydic. 2005. C57BL/6 J and B6.V-LEPOB mice differ in the cholinergic modulation of sleep and breathing. J Appl Physiol 98:918–929.PubMedGoogle Scholar
  81. Drover, D. 2006. Patient State Index. Best Pract Res Clin Anaesthesiol 20:121–128.PubMedGoogle Scholar
  82. Dzoljic, M. R., O. E. Ukponmwan, and P. R. Saxena. 1992. 5-HT1-like receptor agonists enhance wakefulness. Neuropharmacology 31:623–633.Google Scholar
  83. Eckert, D. J., and A. Malhotra. 2008. Pathophysiology of adult obstructive sleep apnea. Proc Am Thorac Soc 5:144–153.PubMedGoogle Scholar
  84. Eggermann, E., M. Serafin, L. Bayer, D. Machard, B. Saint-Mleux, B. E. Jones, and M. Muhlethaler. 2001. Orexins/hypocretins excite basal forebrain cholinergic neurones. Neuroscience 108:177–181.Google Scholar
  85. Elazar, Z., and A. Berchanski. 2001. Glutamatergic-cholinergic synergistic interaction in the pontine reticular formation. Effects on catalepsy. Naunyn Schemiedbergs Arch Pharmacol 363:569–576.Google Scholar
  86. Elmenhorst, D., R. Basheer, R. W. McCarley, and A. Bauer. 2009. Sleep deprivation increases A1 adenosine receptor density in the rat brain. Brain Res 1258:53–58.PubMedGoogle Scholar
  87. Eriksson, K. S., O. Sergeeva, R. E. Brown, and H. L. Haas. 2001. Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J Neurosci 21:9273–9279.PubMedGoogle Scholar
  88. España, R. A., B. A. Baldo, A. E. Kelley, and C. W. Berridge. 2001. Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action. Neuroscience 106:699–715.PubMedGoogle Scholar
  89. España, R. A., and T. E. Scammell. 2004. Sleep neurobiology for the clinician. Sleep 27:811–820.PubMedGoogle Scholar
  90. Fadel, J., R. Pasumarthi, and L. R. Reznikov. 2005. Stimulation of cortical acetylcholine release by orexin A. Neuroscience 130:541–547.PubMedGoogle Scholar
  91. Fallon, J. H., and R. Y. Moore. 1978. Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J Comp Neurol 180:545–580.PubMedGoogle Scholar
  92. Faulhaber, J., A. Steiger, and M. Lancel. 1997. The GABAA agonist THIP produces slow wave sleep and reduces spindling activity in NREM sleep in humans. Psychopharmacol (Berl) 130:285–291.Google Scholar
  93. Feldman, M. 1971. Physiological observations in a chronic case of “locked in” syndrome. Neurology 21:459–478.PubMedGoogle Scholar
  94. Findlay, A. L., and J. N. Hayward. 1969. Spontaneous activity of single neurones in the hypothalamus of rabbits during sleep and waking. J Physiol 201:237–258.PubMedGoogle Scholar
  95. Fink, K. B., and M. Gothert. 2007. 5-HT receptor regulation of neurotransmitter release. Pharmacol Rev 59:360–417.PubMedGoogle Scholar
  96. Fiske, E., J. Grønli, B. Bjorvatn, R. Ursin, and C. M. Portas. 2006. The effect of GABAA antagonist bicuculline on dorsal raphé nucleus and frontal cortex extracellular serotonin: a window on SWS and REM sleep modulation. Pharmacol Biochem Behav 83:314–321.PubMedGoogle Scholar
  97. Florin-Lechner, S. M., J. P. Druhan, G. Aston-Jones, and R. J. Valentino. 1996. Enhanced nor-epinephrine release in prefrontal cortex with burst stimulation of the locus coeruleus. Brain Res 742:89–97.PubMedGoogle Scholar
  98. Foote, S. L., G. Aston-Jones, and F. E. Bloom. 1980. Impulse activity of locus coeruleus neurons in awake rats and monkeys is a function of sensory stimulation and arousal. Proc Natl Acad Sci USA 77:3033–3037.PubMedGoogle Scholar
  99. Franks, N. P. 2008. General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal. Nat Rev Neurosci 9:370–386.PubMedGoogle Scholar
  100. Freeman, A., B. Ciliax, R. Bakay, J. Daley, R. D. Miller, G. Keating, A. Levey, and D. Rye. 2001. Nigrostriatal collaterals to thalamus degenerate in parkinsonian animal models. Ann Neurol 76:403–425.Google Scholar
  101. George, R., W. L. Haslett, and D. J. Jenden. 1964. A cholinergic mechanism in the brainstem reticular formation: induction of paradoxical sleep. Int J Neuropharmacol 72:541–552.Google Scholar
  102. Gerashchenko, D., C. Blanco-Centurian, M. A. Greco, and P. J. Shiromani. 2003. Effects of lateral hypothalamic lesion with the neurotoxin hypocretin-2-saporin on sleep in Long-Evans rats. Neuroscience 116:223–235.PubMedGoogle Scholar
  103. Gerashchenko, D., and P. J. Shiromani. 2004. Effects of inflammation produced by chronic lipopolysaccharide administration on the survival of hypocretin neurons and sleep. Brain Res 1019:162–169.PubMedGoogle Scholar
  104. Gerashchenko, D., J. P. Wisor, D. Burns, R. K. Reh, P. J. Shiromani, T. Sakurai, H. O. de la Iglesia, and T. S. Kilduff. 2008. Identification of a population of sleep-active cerebral cortex neurons. Proc Natl Acad Sci USA 105:10227–10232.PubMedGoogle Scholar
  105. Giovannini, M. G., L. Bartolini, S. R. Kopf, and G. Pepeu. 1998. Acetylcholine release from the frontal cortex during exploratory activity. Brain Res 784:218–227.PubMedGoogle Scholar
  106. Gironell, A., M. D. de la Calzada, T. Sagales, and L. Barraquer-Bordas. 1995. Absence of REM sleep and altered non-REM sleep caused by a haematoma in the pontine tegmentum. J Neurol Neurosurg Psychiatry 59:195–196.PubMedGoogle Scholar
  107. Greco, M. A., P. M. Fuller, T. C. Jhou, S. Martin-Schild, J. E. Zadina, Z. Hu, P. Shiromani, and J. Lu. 2008. Opioidergic projections to sleep-active neurons in the ventrolateral preoptic nucleus. Brain Res 1245:96–107.PubMedGoogle Scholar
  108. Greco, M. A., and P. J. Shiromani. 2001. Hypocretin receptor protein and mRNA expression in the dorsolateral pons of rats. Mol Brain Res 88:176–182.PubMedGoogle Scholar
  109. Greene, R. W., and D. O. Carpenter. 1985. Actions of neurotransmitters on pontine medial reticular formation neurons of cat. J Neurophysiol 54:520–531.PubMedGoogle Scholar
  110. Haas, H. L, and P. Panula. 2003. The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci 4:121–130.PubMedGoogle Scholar
  111. Hagan, J. J., R. A. Leslie, S. Patel, M. L. Evans, T. A. Wattam, S. Holmes, C. D. Benham, S. G. Taylor, C. Routledge, P. Hemmati, R. P. Munton, T. E. Ashmeade, A. S. Shah, J. P. Hatcher, P. D. Hatcher, D. N. C. Jones, M. I. Smith, D. C. Piper, A. J. Hunter, R. A. Porter, and N. Upton. 1999. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci USA 96:10911–10916.PubMedGoogle Scholar
  112. Halassa, M. M., T. Fellin, and P. G. Haydon. 2007. The tripartite synapse: roles for gliotransmission in health and disease. Trends Mol Med 13:54–63.PubMedGoogle Scholar
  113. Halassa, M. M., C. Florian, T. Fellin, J. R. Munoz, S.-Y. Lee, T. Abel, P. G. Haydon, and M. G. Frank. 2009. Astrocytic modulation of sleep homeostasis and cognitive consequences of sleep loss. Neuron 61:213–219.PubMedGoogle Scholar
  114. Hara, J., C. T. Beuckmann, T. Nambu, J. T. Willie, R. M. Chemelli, C. M. Sinton, F. Sugiyama, K.-I. Yagami, K. Goto, M. Yanagisawa, and T. Sakurai. 2001. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 30:345–354.PubMedGoogle Scholar
  115. Hascup, K. N., E. R. Hascup, F. Pomerleau, P. Huettl, and G. A. Gerhardt. 2008. Second-by-second measures of L-glutamate in the prefrontal cortex and striatum of freely moving mice. J Pharmacol Exp Ther 324:725–731.PubMedGoogle Scholar
  116. Hein, L. 2006. Adrenoceptors and signal transduction in neurons. Cell Tissue Res 326:541–551.PubMedGoogle Scholar
  117. Hermans, A., R. B. Keithley, J. M. Kita, L. A. Sombers, and R. M. Wightman. 2008. Dopamine detection with fast-scan cyclic voltammetry used with analog background subtraction. Anal Chem 80:4040–4048.PubMedGoogle Scholar
  118. Hernandez-Peon, R., G. Chavez-Ibarra, P. J. Morgane, and C. Timo-Iaria. 1963. Limbic cholinergic pathways involved in sleep and emotional behavior. Exp Neurol 8:93–111.Google Scholar
  119. Hervieu, G. J., J. E. Cluderay, D. C. Harrison, J. C. Roberts, and R. A. Leslie. 2001. Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Neuroscience 103:777–792.PubMedGoogle Scholar
  120. Himukashi, S., Y. Miyazaki, H. Takeshima, S. Koyanagi, K. Mukaida, T. Shichino, H. Uga, and K. Fukuda. 2005. Nociceptin system does not affect MAC of volatile anesthetics. Acta Anaesthesiol Scand 49:771–773.PubMedGoogle Scholar
  121. Hobson, J. A. 1978. What is a behavioral state? Paper read at Neuroscience Symposia Vol. III: Aspects of behavioral neurobiology, at Bethesda, MD.Google Scholar
  122. Hobson, J. A. 2002. Dreaming: An Introduction to the Science of Sleep. New York: Oxford University Press Inc.Google Scholar
  123. Hobson, J. A., R. W. McCarley, and P. W. Wyzinski. 1975. Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups. Science 189:55–58.PubMedGoogle Scholar
  124. Hogg, R. C., M. Raggenbass, and D. Bertrand. 2003. Nicotinic acetylcholine receptors: from structure to function. Rev Physiol Biochem Pharmacol 147:1–46.PubMedGoogle Scholar
  125. Hong, Z.-Y., Z.-L. Huang, W.-M. Qu, and N. Eguchi. 2005. Orexin A promotes histamine, but not norepinephrine or serotonin, release in frontal cortex of mice. Acta Pharmacol Sin 26:155–159.PubMedGoogle Scholar
  126. Horvath, T. L., C. Peyron, S. Diano, A. Ivanov, G. Aston-Jones, T. S. Kilduff, and A. N. van den Pol. 1999. Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J Comp Neurol 415:145–159.PubMedGoogle Scholar
  127. Houdouin, F., R. Cespuglio, and M. Jouvet. 1991. Effects induced by the electrical stimulation of the nucleus raphé dorsalis upon hypothalamic release of 5-hydroxyindole compounds and sleep parameters in the rat. Brain Res 565:48–56.PubMedGoogle Scholar
  128. Hudetz, A. G. 2008. Are we unconscious during general anesthesia? Int Anesthesiol Clin 46:25–42.PubMedGoogle Scholar
  129. Hudetz, A. G., J. D. Wood, and J. P. Kampine. 2003. Cholinergic reversal of isoflurane anesthesia in rats as measured by cross-approximate entropy of the electroencephalogram. Anesthesiology 99:1125–1131.PubMedGoogle Scholar
  130. Huitron-Resendiz, S., M. P. Kristensen, M. Sánchez-Alavez, S. D. Clark, S. L. Grupke, C. Tyler, C. Suzuki, H.-P. Nothacker, O. Civelli, J. R. Criado, S. J. Henriksen, C. S. Leonard, and L. de Lecea. 2005. Urotensin II modulates rapid eye movement sleep through activation of brainstem cholinergic neurons. J Neurosci 25:5465–5474.PubMedGoogle Scholar
  131. Iber, C., S. Ancoli-Israel, A. L. Chesson Jr, and S. F. Quan. 2007. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology, and Technical Specifications. Westchester: American Academy of Sleep Medicine.Google Scholar
  132. Inagaki, N., A. Yamatodani, M. Ando-Yamamoto, M. Tohyama, T. Watanabe, and H. Wada. 1988. Organization of histaminergic fibers in rat brain. J Comp Neurol 273:283–300.PubMedGoogle Scholar
  133. Isaac, S. O., and C. W. Berridge. 2003. Wake-promoting actions of dopamine D1 and D2 receptor stimulation. J Pharmacol Exp Ther 307:386–394.PubMedGoogle Scholar
  134. Ishii, M., and Y. Kurachi. 2006. Muscarinic acetylcholine receptors. Curr Pharm Des 12:3573–3581.PubMedGoogle Scholar
  135. Ishizuka, T., Y. Yamamoto, and A. Yamatodani. 2002. The effect of orexin-A and -B on the histamine release in the anterior hypothalamus in rats. Neurosci Lett 323:93–96.PubMedGoogle Scholar
  136. Jacob, T. C., S. J. Moss, and R. Jurd. 2008. GABAA receptor trafficking and its role in the dynamic modulation of neuronal inhibition. Nat Rev Neurosci 9:331–343.PubMedGoogle Scholar
  137. Jacobs, B. L. 1986. Single unit activity of locus coeruleus neurons in behaving animals. Prog Neurobiol 27:183–194.PubMedGoogle Scholar
  138. Jasper, H. H., and J. Tessier. 1971. Acetylcholine liberation from cerebral cortex during paradoxical (REM) sleep. Science 172:601–602.PubMedGoogle Scholar
  139. Johansen, J. W. 2006. Update on bispectral index monitoring. Best Pract Res Clin Anaesthesiol 20:81–99.PubMedGoogle Scholar
  140. John, J., L. Ramanathan, and J. M. Siegel. 2008. Rapid changes in glutamate levels in the posterior hypothalamus across sleep-wake states in freely behaving rats. Am J Physiol Regul Integr Comp Physiol 295:R2041–R2049.PubMedGoogle Scholar
  141. Johnson, M. D., R. K. Franklin, M. D. Gibson, R. B. Brown, and D. R. Kipke. 2008. Implantable microelectrode arrays for simultaneous electrophysiological and neurochemical recordings. J Neurosci Methods 174:62–70.PubMedGoogle Scholar
  142. Jones, B. E. 2003. Arousal states. Front Biosci 8:S438–S451.PubMedGoogle Scholar
  143. Jones, B. E., and A. Beaudet. 1987. Distribution of acetylcholine and catecholamine neurons in the cat brainstem: a choline acetyltransferase and tyrosine hydroxylase immunohistochemical study. J Comp Neurol 261:15–32.PubMedGoogle Scholar
  144. Jones, B. E., and A. C. Cuello. 1989. Afferents to the basal forebrain cholinergic cell area from pontomesencephalic-catecholamine, serotonin, and acetylcholine-neurons. Neuroscience 31:37–61.PubMedGoogle Scholar
  145. Jouvet, M. 1962. Recherches sur les structures nerveuses et les mécanisms responsables des différentes phases du sommeil physiologique. Arch Ital Biol 100:125–206.PubMedGoogle Scholar
  146. Jouvet, M. 1965. Paradoxical sleep-a study of its nature and mechanisms. Prog Brain Res 18:20–62.PubMedGoogle Scholar
  147. Jouvet, M. 1969. Biogenic amines and the states of sleep. Science 163:32–41.PubMedGoogle Scholar
  148. Jouvet, M., and F. Michel. 1959. Corrélations électromyographiques du sommeil chez le chat décortiqué et mésencéphalique chronique. Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales 153:422–425.PubMedGoogle Scholar
  149. Jouvet, M., F. Michel, and J. Courjon. 1959. Sur la mise en jeu de deux mécaisemes á expression électro-encéphalographique différente au cours du sommeil physiologique chez le chat. Comptes Rendus Hebdomadaires Des Seances de l Academie des Sciences 248:3043–3045.PubMedGoogle Scholar
  150. Jouvet, M, F. Michel, and J. Courjon. 1959. Sur un stade d’activité électrique rapide au cours du sommeil physiologique. Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales 153:1024–1028.PubMedGoogle Scholar
  151. Kaitin, K. I. 1984. Preoptic area unit activity during sleep and wakefulness in the cat. Exp Neurol 83:347–357.PubMedGoogle Scholar
  152. Kaneko, T., K. Itoh, R. Shigemoto, and N. Mizuno. 1989. Glutaminase-like immunoreactivity in the lower brainstem and cerebellum of the adult rat. Neuroscience 32:79–98.PubMedGoogle Scholar
  153. Kaneko, Y., K. Shimada, K. Saitou, Y. Sugimoto, and C. Kamei. 2000. The mechanism responsible for the drowsiness caused by first generation H1 antagonists on the EEG pattern. Methods Find Exp Clin Pharm 22:163–168.Google Scholar
  154. Kehr, J., and U. Ungerstedt. 1988. Fast HPLC estimation of gamma-aminobutyric acid in microdialysis perfusates: effects of nipecotic and 3-mecaptopropionic acids. J Neurochem 51:1308–1310.PubMedGoogle Scholar
  155. Keifer, J. C., H. A. Baghdoyan, L. Becker, and R. Lydic. 1994. Halothane decreases pontine acetylcholine release and increases EEG spindles. Neuroreport 5:577–580.PubMedGoogle Scholar
  156. Keifer, J. C., H. A. Baghdoyan, and R. Lydic. 1992. Sleep disruption and increased apneas after pontine microinjection of morphine. Anesthesiology 77:973–982.PubMedGoogle Scholar
  157. Kelz, M. B., Y. Sun, J. Chen, Q. C. Meng, J. T. Moore, S. C. Veasey, S. Dixon, M. Thornton, H. Funato, and M. Yanagisawa. 2008. An essential role for orexins in emergence from general anesthesia. Proc Natl Acad Sci USA 105:1309–1314.PubMedGoogle Scholar
  158. Kennedy, R. T., J. E. Thompson, and T. W. Vickroy. 2002. In vivo monitoring of amino acids by direct sampling of brain extracellular fluid at ultralow flow rates and capillary electrophoresis. J Neurosci Methods 114:39–49.PubMedGoogle Scholar
  159. Kim, J., K. Nakajima, Y. Oomora, M. J. Wayner, and K. Sasaki. 2009. Electrophysiological effects of ghrelin on pedunculopontine tegmental neurons in rats: an in vitro study. Peptides 30:745–757.Google Scholar
  160. Kimura, K., N. Tachibana, J. Kohyama, Y. Otsuka, S. Fukazawa, and R. Waki. 2000. A discrete pontine ischemic lesion could cause REM sleep behavior disorder. Neurology 55:894–895.PubMedGoogle Scholar
  161. Kitsikis, A., and M. Steriade. 1981. Immediate behavioral effects of kainic acid injections into the midbrain reticular core. Behav Brain Res 3:361–380.PubMedGoogle Scholar
  162. Kiyashchenko, L. I., B. Y. Mileykovskiy, N. Maidment, H. A. Lam, M.-F. Wu, J. John, J. Peever, and J. M. Siegel. 2002. Release of hypocretin (orexin) during waking and sleep states. J Neurosci 22:5282–5286.PubMedGoogle Scholar
  163. Kiyono, S., M. L. Seo, M. Shibagaki, T. Watanabe, K. Maeyama, and H. Wada. 1985. Effects of α-fluoromethylhistidine on sleep-waking parameters in rats. Physiol Behav 34:615–617.PubMedGoogle Scholar
  164. Ko, E. M., I. V. Estabrooke, M. McCarthy, and T. E. Scammell. 2003. Wake-related activity of tuberomammillary neurons in rats. Brain Res 992:220–226.PubMedGoogle Scholar
  165. Kodama, T., Y. Takahashi, and Y. Honda. 1990. Enhancement of acetylcholine release during paradoxical sleep in the dorsal tegmental field of the cat brain stem. Neurosci Lett 114:277–282.PubMedGoogle Scholar
  166. Kohlmeier, K. A., J. Burns, P. B. Reiner, and K. Semba. 2002. Substance P in the descending cholinergic projection to REM sleep-induction regions of the rat pontine reticular formation: anatomical and electrophysiological analyses. Eur J Neurosci 15:176–196.PubMedGoogle Scholar
  167. Kottegota, S., I. Shaik, and S. A. Shippy. 2002. Demonstration of low flow push–pull perfusion. J Neurosci Methods 121:93–101.Google Scholar
  168. Koyama, Y., and O. Hayaishi. 1994. Firing of neurons in the preoptic/anterior hypothalamic areas in rat: its possible involvement in slow wave sleep and paradoxical sleep. Neurosci Res 19:31–38.PubMedGoogle Scholar
  169. Koyama, Y., T. Kodama, K. Takahashi, K. Okai, and Y. Kayama. 2002. Firing properties of neurones in the laterodorsal hypothalamic area during sleep and wakefulness. Psychiat Clin Neurosci 56:339–340.Google Scholar
  170. Kreuer, S. 2006. The Narcotrend monitor. Best Pract Res Clin Anaesthesiol 20:111–119.PubMedGoogle Scholar
  171. Kshatri, A. M., H. A. Baghdoyan, and R. Lydic. 1998. Cholinomimetics, but not morphine, increase antinociceptive behavior from pontine reticular regions regulating rapid eye movement sleep. Sleep 21:677–685.PubMedGoogle Scholar
  172. Kumar, V. M., S. Datta, G. S. Chhina, and B. Singh. 1986. Alpha adrenergic system in medial preoptic area in sleep-wakefulness in rats. Brain Res Bull 16:463–468.Google Scholar
  173. Kurosawa, M., K. Okada, A. Sato, and S. Uchida. 1993. Extracellular release of acetylcholine, noradrenaline and serotonin increases in the cerebral cortex during walking in conscious rats. Neurosci Lett 161:73–76.PubMedGoogle Scholar
  174. Kushikata, T., K. Hirota, H. Yoshida, M. Kudo, D. G. Lambert, D. Smart, J. C. Jerman, and A. Matsuki. 2003. Orexinergic neurons and barbiturate anesthesia. Neuroscience 121:855–863.PubMedGoogle Scholar
  175. Lai, Y. Y., and J. M. Siegel. 1988. Medullary regions mediating atonia. J Neurosci 8:4790–4796.PubMedGoogle Scholar
  176. Lai, Y. Y., and J. M. Siegel. 1991. Pontomedullary glutamate receptors mediating locomotion and muscle tone suppression. J Neurosci 11:2931–2937.PubMedGoogle Scholar
  177. Lancel, M. 1997. The GABAA agonist THIP increases non-REM sleep and enhances non-REM sleep-specific delta activity in the rat during the dark period. Sleep 20:1099–1104.PubMedGoogle Scholar
  178. Landolt, H. P., D. J. Dijk, S. E. Gaus, and A. A. Borbely. 1995. Caffeine reduces low-frequency delta activity in the human sleep EEG. Neuropsychopharmacol 12:229–238.Google Scholar
  179. Landolt, H. P., E. Werth, A. A. Borbely, and D. J. Dijk. 1995. Caffeine intake (200 mg) in the morning affects human sleep and EEG power spectra at night. Brain Res 675:67–74.PubMedGoogle Scholar
  180. Laposky, A. D., M. A. Bradley, D. L. Williams, J. Bass, and F. W. Turek. 2008. Sleep-wake regulation is altered in leptin-resistant (db/db) genetically obese and diabetic mice. Am J Physiol Regul Integr Comp Physiol 295:R2059–R2066.PubMedGoogle Scholar
  181. Laposky, A. D., J. Shelton, J. Bass, C. Dugovic, N. Perrino, and F. W. Turek. 2006. Altered sleep regulation in leptin-deficient mice. Am J Physiol Regul Integr Comp Physiol 290:R894–R903.PubMedGoogle Scholar
  182. Laureys, S., and G. Tononi, eds. 2009. The Neurology of Consciousness: Cognitive Neuroscience and Neuropathology. Burlington: Academic Press.Google Scholar
  183. Lavie, P., H. Pratt, B. Scharf, R. Peled, and J. Brown. 1984. Localized pontine lesion: nearly total absence of REM sleep. Neurology 34:118–120.PubMedGoogle Scholar
  184. Le, S., J. A. Gruner, J. R. Mathiasen, M. J. Marino, and H. Schaffhauser. 2008. Correlation between ex vivo receptor occupancy and wake-promoting activity of selective H3 receptor antagonists. J Pharmacol Exp Ther 325:902–909.PubMedGoogle Scholar
  185. Lee, M. G., O. K. Hassani, and B. E. Jones. 2005. Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle. J Neurosci 25:6716–6720.PubMedGoogle Scholar
  186. Leonard, T. O., and R. Lydic. 1995. Nitric oxide synthase inhibition decreases pontine acetylcholine release. Neuroreport 6:1525–1529.PubMedGoogle Scholar
  187. Leonard, T. O., and R. Lydic. 1997. Pontine nitric oxide modulates acetylcholine release, rapid eye movement sleep generation, and respiratory rate. J Neurosci 17:774–785.PubMedGoogle Scholar
  188. Li, Y., and A. N. van den Pol. 2008. μ-opioid receptor-mediated depression of the hypothalamic hypocretin/orexin arousal system. J Neurosci 28:2814–2819.PubMedGoogle Scholar
  189. Ligneau, X., D. Perrin, L. Landais, J.-C. Camelin, T. P. G. Calmels, I. Berrebi-Bertrand, J.-M. Lecomte, R. Parmentier, C. Anaclet, J. S. Lin, V. Bertaina-Anglade, C. Drieu la Rochelle, F. d’Aniello, A. Rouleau, F. Gbahou, J. M. Arrang, C. R. Ganellin, H. Stark, W. Schunack, and J. C. Schwartz. 2007. BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: preclinical pharmacology. J Pharmacol Exp Ther 320:365–375.PubMedGoogle Scholar
  190. Lin, J. S., K. Sakai, and M. Jouvet. 1988. Evidence for histaminergic arousal mechanisms in the hypothalamus of cats. Neuropharmacology 27:111–122.Google Scholar
  191. Lin, J. S., K. Sakai, G. Vanni-Mercier, and M. Jouvet. 1989. A critical role of the posterior hypothalamus in the mechanisms of wakefulness determined by microinjection of muscimol in freely moving cats. Brain Res 479:225–240.PubMedGoogle Scholar
  192. Lin, L., J. Faraco, R. Li, H. Kadotani, W. Rogers, X. Lin, X. Qiu, P. J. de Jong, S. Nishino, and E. Mignot. 1999. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98:365–376.PubMedGoogle Scholar
  193. Lincoln, D. W. 1969. Correlation of unit activity in the hypothalamus with EEG patterns associated with the sleep cycle. Exp Neurol 24:1–18.PubMedGoogle Scholar
  194. Liu, R.-J., A. N. van den Pol, and G. K. Aghajanian. 2002. Hypocretins (orexins) regulate serotonin neurons in the dorsal raphé nucleus by excitatory direct and inhibitory indirect actions. J Neurosci 22:9453–9464.PubMedGoogle Scholar
  195. Liu, Z.-W., and X. B. Gao. 2007. Adenosine inhibits activity of hypocretin/orexin neurons by the A1 receptor in the lateral hypothalamus: a possible sleep-promoting effect. J Neurophysiol 97:837–848.PubMedGoogle Scholar
  196. Loomis, A. L., E. N. Harvey, and G. Hobart. 1935. Further observations on the potential rhythms of the cerebral cortex during sleep. Science 82:198–200.PubMedGoogle Scholar
  197. Loomis, A. L., E. N. Harvey, and G. Hobart. 1935. Potential rhythms of the cerebral cortex during sleep. Science 81:597–598.PubMedGoogle Scholar
  198. Loomis, A. L., E. N. Harvey, and G. Hobart. 1937. Cerebral states during sleep, as studied by human brain potentials. J Exp Psych 21:127–144.Google Scholar
  199. Loomis, A. L., E. N. Harvey, and G. Hobart. 1938. Distribution of disturbance-patterns in the human electroencephalogram, with special reference to sleep. J Neurophysiol 1:413–430.Google Scholar
  200. Lu, J., L. E. Nelson, N. Franks, M. Maze, N. L. Chamberlin, and C. B. Saper. 2008. Role of endogenous sleep-wake and analgesic systems in anesthesia. J Comp Neurol 508:648–662.PubMedGoogle Scholar
  201. Lydic, R. 1996. Reticular modulation of breathing during sleep and anesthesia. Curr Opin Pulm Med 2:474–481.PubMedGoogle Scholar
  202. Lydic, R., and H. A. Baghdoyan. 1993. Pedunculopontine stimulation alters respiration and increases ACh release in the pontine reticular formation. Am J Physiol 264:R544–R554.PubMedGoogle Scholar
  203. Lydic, R., and H. A. Baghdoyan. 2002. Ketamine and MK-801 decrease acetylcholine release in the pontine reticular formation, slow breathing, and disrupt sleep. Sleep 25:615–620.Google Scholar
  204. Lydic, R., and H. A. Baghdoyan. 2005. Sleep, anesthesiology, and the neurobiology of arousal state control. Anesthesiology 103:1268–1295.PubMedGoogle Scholar
  205. Lydic, R., and H. A. Baghdoyan. 2007. Neurochemical mechanisms mediating opioid-induced REM sleep disruption. In Sleep and Pain, edited by G. Lavigne, B. Sessle, M. Choinière and P. Soja. Seattle: IASP Press.Google Scholar
  206. Lydic, R., and J. F. Biebuyck. 1994. Sleep neurobiology: relevance for mechanistic studies of anaesthesia. Br J Anaesth 72:506–508.PubMedGoogle Scholar
  207. Lydic, R., C. L. Douglas, and H. A. Baghdoyan. 2002. Microinjection of neostigmine into the pontine reticular formation of C57BL/6 J mouse enhances rapid eye movement sleep and depresses breathing. Sleep 25:835–841.PubMedGoogle Scholar
  208. Lydic, R., R. W. McCarley, and J. A. Hobson. 1983. The time-course of dorsal raphé discharge, PGO waves, and muscle tone averaged across multiple sleep cycles. Brain Res 274:365–370.PubMedGoogle Scholar
  209. Manohar, S., H. Noda, and W. R. Adey. 1972. Behavior of mesencephalic reticular neurons in sleep and wakefulness. Exp Neurol 34:140–157.PubMedGoogle Scholar
  210. Marcus, J. N., C. N. Aschenasi, C. E. Lee, R. M. Chemelli, C. B. Saper, M. Yanagisawa, and J. K. Elmquist. 2001. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 435:6–25.PubMedGoogle Scholar
  211. Markland, O. N., and M. L. Dyken. 1976. Sleep abnormalities in patients with brain stem lesions. Neurology 26:769–776.Google Scholar
  212. Marks, G. A., O. W. Sachs, and C. G. Birabil. 2008. Blockade of GABA, type A, receptors in the rat pontine reticular formation induces rapid eye movement sleep that is dependent upon the cholinergic system. Neuroscience 156:1–10.PubMedGoogle Scholar
  213. Marrosu, F., C. Portas, M. S. Mascia, M. A. Casu, M. Fa, M. Giagheddu, A. Imperatu, and G. L. Gessa. 1995. Microdialysis measurement of cortical and hippocampal acetylcholine release during sleep-wake cycle in freely moving cats. Brain Res 671:329–332.PubMedGoogle Scholar
  214. Martinez-Mir, M. I., H. Pollard, J. Moreau, J. M. Arrang, M. Ruat, E. Traiffort, J. C. Schwartz, and J. M. Palacios. 1990. Three histamine receptors (H1, H2, and H3) visualized in the brain of human and non-human primates. Brain Res 526:322–327.PubMedGoogle Scholar
  215. Mashour, G. A. 2006. Monitoring consciousness: EEG-based measures of anesthetic depth. Semin Anesth Perioperat Med Pain 25:205–210.Google Scholar
  216. Mashour, G. A. Ed. 2008. Unconscious Processes. Int Anesthesiol Clin 46:1–205.Google Scholar
  217. Materi, L. M., D. D. Rasmusson, and K. Semba. 2000. Inhibition of synaptically evoked cortical acetylcholine release by adenosine: an in vivo microdialysis study in the rat. Neuroscience 97:219–226.PubMedGoogle Scholar
  218. McCarley, R. W. 2007. Neurobiology of REM and NREM sleep. Sleep Med 8:302–330.PubMedGoogle Scholar
  219. McCarley, R. W., and J. A. Hobson. 1975. Neuronal excitability modulation over the sleep cycle: a structural and mathematical model. Science 189:58–60.PubMedGoogle Scholar
  220. McGinty, D. J. 1969. Somnolence, recovery, and hyposomnia following ventro-medial diencephalic lesions in the rat. Electroenceph Clin Neurophysiol 26:70–79.PubMedGoogle Scholar
  221. McGinty, D. J., and R. M. Harper. 1976. Dorsal raphé neurons: depression of firing during sleep in cats. Brain Res 101:569–575.PubMedGoogle Scholar
  222. McGinty, D. J., and M. B. Sterman. 1968. Sleep suppression after basal forebrain lesions in the cat. Science 160:1253–1255.PubMedGoogle Scholar
  223. Mendelson, W. B. 2001. The sleep-inducing effect of ethanol microinjection into the medial preoptic area is blocked by flumazenil. Brain Res 892:118–121.PubMedGoogle Scholar
  224. Mendelson, W. B., J. V. Martin, M. Perlis, and R. Wagner. 1989. Enhancement of sleep by microinjection of triazolam into the medial preoptic area. Neuropsychopharmacol 2:61–66.Google Scholar
  225. Menefee, L. A., M. J. M. Cohen, W. R. Anderson, K. Doghramji, E. D. Frank, and H. Lee. 2000. Sleep disturbance and nonmalignant chronic pain: a comprehensive review of the literature. Pain Med 1:156–172.PubMedGoogle Scholar
  226. Methippara, M. M., M. N. Alam, R. Szymusiak, and D. J. McGinty. 2000. Effects of lateral preoptic area application of orexin-A on sleep-wakefulness. Neuroreport 11:3423–3426.PubMedGoogle Scholar
  227. Meuret, P., S. B. Backman, V. Bonhomme, G. Plourde, and P. Fiset. 2000. Physostigmine reverses propofol-induced unconsciousness and attenuation of the auditory steady state response and bispectral index in human volunteers. Anesthesiology 93:708–717.PubMedGoogle Scholar
  228. Mileykovskiy, B. Y., L. I. Kiyashchenko, and J. M. Siegel. 2005. Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron 46:787–798.PubMedGoogle Scholar
  229. Miller, J. D., J. Farber, P. Gatz, H. Roffwarg, and D. C. German. 1983. Activity of mesencephalic dopamine and non-dopamine neurons across stages of sleep and waking in the rat. Brain Res 273:133–141.PubMedGoogle Scholar
  230. Missale, C., S. R. Nash, S. W. Robinson, M. Jaber, and M. G. Caron. 1998. Dopamine receptors: from structure to function. Physiol Rev 78:189–225.PubMedGoogle Scholar
  231. Mitani, A., K. Ito, A. E. Hallanger, B. H. Wainer, K. Kataoka, and R. W. McCarley. 1988. Cholinergic projections from the laterodorsal and pedunculopontine tegmental nuclei to the pontine gigantocellular field in the cat. Brain Res 451:397–402.PubMedGoogle Scholar
  232. Mobarakeh, J. I., K. Takahashi, S. Sakurada, S. Nishino, T. Watanabe, M. Kato, and K. Yanai. 2005. Enhanced antinociception by intracerebroventricularly and intrathecally-administered orexin A and B (hypocretin-1 and -2) in mice. Peptides 26:767–777.PubMedGoogle Scholar
  233. Moldofsky, H. 2001. Sleep and Pain. Sleep Med Rev 5:387–398.Google Scholar
  234. Monti, J. M., L. D’Angelo, H. Jantos, and S. Pazos. 1988. Effects of a-fluoromethylhistidine on sleep and wakefulness in the rat. J Neural Transm 72:141–145.PubMedGoogle Scholar
  235. Monti, J. M., M. Fernandez, and H. Jantos. 1990. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats. Neuropsychopharmacol 3:153–162.Google Scholar
  236. Monti, J. M., M. Hawkins, H. Jantos, L. D’Angelo, and M. Fernandez. 1988. Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat. Psychopharmacol (Berl) 95:395–400.Google Scholar
  237. Monti, J. M., and H. Jantos. 1992. Dose-dependent effects of the 5-HT1A receptor agonist 8-OH-DPAT on sleep and wakefulness in the rat. J Sleep Res 1:169–175.PubMedGoogle Scholar
  238. Monti, J. M., and H. Jantos. 2006a. Effects of activation and blockade of 5-HT2A/2C receptors in the dorsal raphé nucleus on sleep and waking in the rat. Prog Neuropsychopharmacol Biol Psychiatry 30:1189–1195.PubMedGoogle Scholar
  239. Monti, J. M., and H. Jantos. 2006b. Effects of the serotonin 5-HT2A/2C receptor agonist DOI and of the selective 5-HT2A or 5-HT2C receptor antagonists EMD 281014 and SB-243213, respectively, on sleep and waking in the rat. Eur J Pharmacol 553:163–170.PubMedGoogle Scholar
  240. Monti, J. M., H. Jantos, and M. Fernandez. 1989. Effects of the selective dopamine D-2 receptor agonist, quinpirole on sleep and wakefulness in the rat. Eur J Pharmacol 169:61–66.PubMedGoogle Scholar
  241. Monti, J. M., S. R. Pandi-Perumal, and C. M. Sinton, eds. 2008. Neurochemistry of Sleep and Wakefulness. New York: Cambridge University Press.Google Scholar
  242. Mooney, M. E., D. V. Herin, J. M. Schmitz, N. Moukaddam, C. E. Green, and J. Grabowski. 2009. Effects of oral methamphetamine on cocaine use: a randomized, double blind, placebo-controlled trial. Drug Alcohol Depend 101:34–41.PubMedGoogle Scholar
  243. Moreno-Balandran, M. E., M. Garzon, C. Bodalo, F. Reinoso-Suárez, and I. de Andrés. 2008. Sleep-wakefulness effects after microinjections of hypocretin-1 (orexin A) in cholinoceptive areas of the cat oral pontine tegmentum. Eur J Neurosci 28:331–341.PubMedGoogle Scholar
  244. Moriarty, S., L. Hedley, J. Flores, R. Martin, and T. S. Kilduff. 2008. Selective 5-HT2A and 5-HT6 receptor antagonists promote sleep in rats. Sleep 31:34–44.Google Scholar
  245. Morrow, J. D., S. Vikraman, L. Imeri, and M. R. Opp. 2008. Effects of serotonergic activation by 5-hydroxytryptophan on sleep and body temperature of C57BL/6 J and interleukin-6-deficient mice are dose and time related. Sleep 31:21–33.PubMedGoogle Scholar
  246. Moruzzi, G. 1964. Reticular influences on the EEG. Clin Neurophysiol 16:2–17.Google Scholar
  247. Moruzzi, G., and H. W. Magoun. 1949. Brain stem reticular formation and activation of the EEG. Electroenceph Clin Neurophysiol 1:455–473.PubMedGoogle Scholar
  248. Murillo-Rodriguez, E., M. Liu, C. Blanco-Centurian, and P. J. Shiromani. 2008. Effects of hypocretin (orexin) neuronal loss on sleep and extracellular adenosine levels in the rat basal forebrain. Eur J Neurosci 28:1191–1198.PubMedGoogle Scholar
  249. Nambu, T., T. Sakurai, K. Mizukami, Y. Hosoya, M. Yanagisawa, and K. Goto. 1999. Distribution of orexin neurons in the adult rat brain. Brain Res 827:243–260.PubMedGoogle Scholar
  250. Nauta, W. J. H. 1946. Hypothalamic regulation of sleep in rats. An experimental study. J Neurophysiol 9:285–316.PubMedGoogle Scholar
  251. Nicholson, A. N., and B. M. Stine. 1986. Antihistamines: impaired performance and the tendency to sleep. Eur J Clin Pharmacol 30:27–32.PubMedGoogle Scholar
  252. Nishino, S., and T. Kanbayashi. 2005. Symptomatic narcolepsy, cataplexy, and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Med Rev 9:269–310.PubMedGoogle Scholar
  253. Nishino, S., B. Ripley, S. Overeem, G. J. Lammers, and E. Mignot. 2000. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355:39–40.PubMedGoogle Scholar
  254. Nishino, S., and T. Sakurai, eds. 2005. The Orexin/Hypocretin System: Physiology and Pathophysiology. Totowa, NJ: Humana Press Inc.Google Scholar
  255. Nitz, D., and J. M. Siegel. 1996. GABA release in posterior hypothalamus across sleep-wake cycle. Am J Physiol 271:R1707–R1712.PubMedGoogle Scholar
  256. Núñez, A., W. Buño, and F. Reinoso-Suárez. 1998. Neurotransmitter actions on oral pontine tegmental neurons of the rat: an in vitro study. Brain Res 804:144–148.PubMedGoogle Scholar
  257. Núñez, A., M. E. Moreno-Balandran, M. L. Rodrigo-Angulo, M. Garzon, and I. de Andrés. 2006. Relationship between the perifornical hypothalamic area and oral pontine reticular nucleus in the rat. Possible implication of the hypocretinergic projection in the control of rapid eye movement sleep. Eur J Neurosci 24:2834–2842.PubMedGoogle Scholar
  258. Oishi, Y., Z.-L. Huang, B. B. Fredholm, Y. Urade, and O. Hayaishi. 2008. Adenosine in the tuberomammillary nucleus inhibits the histaminergic system via A1 receptors and promotes non-rapid eye movement sleep. Proc Natl Acad Sci USA 105:19992–19997.PubMedGoogle Scholar
  259. Onoe, H., and K. Sakai. 1995. Kainate receptors: a novel mechanism in paradoxical (REM) sleep generation. Neuroreport 6:353–356.PubMedGoogle Scholar
  260. Orser, B. A. 2006. Extrasynaptic GABAA receptors are critical targets for sedative-hypnotic drugs. J Clin Sleep Med 2:S12–S18.PubMedGoogle Scholar
  261. Orser, B. A. 2007. Lifting the fog around anesthesia. Sci Am 296:54–61.PubMedGoogle Scholar
  262. Osman, N. I., H. A. Baghdoyan, and R. Lydic. 2005. Morphine inhibits acetylcholine release in rat prefrontal cortex when delivered systemically or by microdialysis to basal forebrain. Anesthesiology 103:779–787.PubMedGoogle Scholar
  263. Pal, D., and B. N. Mallick. 2006. Role of noradrenergic and GABA-ergic inputs in pedunculopontine tegmentum for regulation of rapid eye movement sleep in rats. Neuropharmacology 51:1–11.PubMedGoogle Scholar
  264. Panula, P., S. Pirvola, S. Auvinen, and M. S. Airaksinen. 1989. Histamine-immunoreactive nerve fibers in the rat brain. Neuroscience 28:585–610.PubMedGoogle Scholar
  265. Panula, P., H.-Y. T. Yang, and E. Costa. 1984. Histamine-containing neurons in the rat hypothalamus. Proc Natl Acad Sci USA 81:2572–2576.PubMedGoogle Scholar
  266. Parmentier, R., C. Anaclet, C. Guhennec, E. Brousseau, D. Bricout, T. Giboulot, D. Bozyczko-Coyne, K. Spiegel, H. Ohtsu, M. Williams, and J. S. Lin. 2007. The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders. Biochem Pharmacol 73:1157–1171.PubMedGoogle Scholar
  267. Paxinos, G., and C. Watson. 2007. The Rat Brain in Stereotaxic Coordinates, 6th ed. New York: Academic Press.Google Scholar
  268. Peyron, C., J. Faraco, W. Rogers, B. Ripley, S. Overeem, Y. Charnay, S. Nevsimalova, M. Aldrich, D. Reynolds, R. Albin, R. Li, M. Hungs, M. Pedrazzoli, M. Padigaru, M. Kucherlapati, J. Fan, R. Maki, G. J. Lammers, C. Bouras, R. Kucherlapati, S. Nishino, and E. Mignot. 2000. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6:991–997.PubMedGoogle Scholar
  269. Peyron, C., D. K. Tighe, A. N. van den Pol, L. de Lecea, H. C. Heller, J. G. Sutcliffe, and T. S. Kilduff. 1998. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18:9996–10015.PubMedGoogle Scholar
  270. Phillips, P. E. M., and R. M. Wightman. 2003. Critical guidelines for validation of the selectivity of in-vivo chemical microsensors. Trends Anal Chem 22:509–514.Google Scholar
  271. Piper, D. C., N. Upton, M. I. Smith, and A. J. Hunter. 2000. The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats. Eur J Neurosci 12:726–730.PubMedGoogle Scholar
  272. Plourde, G., D. Chartrand, P. Fiset, S. Font, and S. B. Backman. 2003. Antagonism of sevoflurane anaesthesia by physostigmine: effects on the auditory steady-state response and bispectral index. Br J Anaesth 91:583–586.PubMedGoogle Scholar
  273. Porkka-Heiskanen, T., R. E. Strecker, and R. W. McCarley. 2000. Brain site-specificity of extracellular adenosine concentration changes during sleep deprivation and spontaneous sleep: an in vivo microdialysis study. Neuroscience 99:507–517.PubMedGoogle Scholar
  274. Porkka-Heiskanen, T., R. E. Strecker, M. Thakkar, A. A. Bjorkum, R. W. Greene, and R. W. McCarley. 1997. Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness. Science 276:1265–1268.PubMedGoogle Scholar
  275. Portas, C. M., B. Bjorvatn, S. Fagerland, J. Gronli, V. Mundal, E. Sorensen, and R. Ursin. 1998. On-line detection of extracellular levels of serotonin in dorsal raphé nucleus and frontal cortex over the sleep/wake cycle in the freely moving rat. Neuroscience 83:807–814.PubMedGoogle Scholar
  276. Portas, C. M., M. Thakkar, D. Rainnie, and R. W. McCarley. 1996. Microdialysis perfusion of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the dorsal raphé nucleus decreases serotonin release and increases rapid eye movement sleep in the freely moving cat. J Neurosci 16:2820–2828.PubMedGoogle Scholar
  277. Punjabi, N. M. 2008. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 5:136–143.PubMedGoogle Scholar
  278. Python, A., T. Steimer, Z. de Saint Hilaire, R. Mikolajewski, and S. Nicolaidis. 2001. Extracellular serotonin variations during vigilance states in the preoptic area of rats: a microdialysis study. Brain Res 910:49–54.PubMedGoogle Scholar
  279. Ranson, S. W. 1939. Somnolence caused by hypothalamic lesions in the monkey. Arch Neurol Psychiatry 41:1–23.Google Scholar
  280. Rechtschaffen, A., and A. Kales. 1968. A Manual of Standardized Terminology: Techniques and Scoring System for Sleep Stages of Human Subjects. Washington, DC: US Government Printing Office.Google Scholar
  281. Regoli, D., G. Drapeau, S. Dion, and P. D’Orleans-Juste. 1989. Receptors for substance P and related neurokinins. Pharamacology 38:1–15.Google Scholar
  282. Reinoso-Suarez, F., I. de Andrés, M. L. Rodrigo-Angulo, and M. Garzón. 2001. Brain structures and mechanisms involved in the generation of REM sleep. Sleep Med Rev 5:63–77.PubMedGoogle Scholar
  283. Robinson, D. L., A. Hermans, A. T. Seipel, and R. M. Wightman. 2008. Monitoring rapid chemical communication in the brain. Chem Rev 108:2554–2584.PubMedGoogle Scholar
  284. Roehrs, T., and T. Roth. 2005. Sleep and pain: interaction of two vital functions. Semin Neurol 25:106–116.PubMedGoogle Scholar
  285. Roth, T., R. Rogowski, S. Hull, H. Schwartz, G. Koshorek, B. Corser, and D. Seiden. 2007. Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia. Sleep 30:1555–1561.PubMedGoogle Scholar
  286. Russell, I. J., A. T. Perkins, J. E. Michalek, and Oxybate SXB-26 Fibromyalgia Syndrome Study Group. 2009. Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial. Arthritis Rheum 60:299–309.PubMedGoogle Scholar
  287. Sagales, T., S. Erill, and E. F. Domino. 1969. Differential effects of scopolamine and chlorpromazine on REM and NREM sleep in normal male subjects. Clin Pharmacol Ther 10:522–529.PubMedGoogle Scholar
  288. Saitou, K., T. Kaneko, Y. Sugimoto, Z. Chen, and C. Kamei. 1999. Slow wave sleep-inducing effects of first generation H1-antagonists. Biol Pharm Bull 22:1079–1082.PubMedGoogle Scholar
  289. Sakai, K., D. Salvert, M. Touret, and M. Jouvet. 1977. Afferent connections of the nucleus raphé dorsalis in the cat as visualized by the horseradish peroxidase technique. Brain Res 137:11–35.PubMedGoogle Scholar
  290. Sakai, K., Y. Yoshimoto, P. H. Luppi, P. Fort, M. El Mansari, D. Salvert, and M. Jouvet. 1990. Lower brainstem afferents to the cat posterior hypothalamus: a double-labeling study. Brain Res Bull 24:437–455.PubMedGoogle Scholar
  291. Sakurai, T., A. Amemiya, M. Ishii, I. Matsuzaki, R. M. Chemelli, H. Tanaka, S. C. Williams, J. A. Richardson, G. P. Kozlowski, S. Wilson, J. R. S. Arch, R. E. Buckingham, A. C. Haynes, S. A. Carr, R. S. Annan, D. E. McNulty, W.-S. Liu, J. A. Terrett, N. A. Elshourbagy, D. J. Bergsma, and M. Yanagisawa. 1998. Orexin and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92:572–595.Google Scholar
  292. Sallanon, M., M. Denoyer, K. Kitahama, C. Aubert, N. Gay, and M. Jouvet. 1989. Long-lasting insomnia induced by neuron lesions and its transient reversal by muscimol injection into the posterior hypothalamus in the cat. Neuroscience 32:669–683.PubMedGoogle Scholar
  293. Sanford, L. D., X. Tang, J. Xiao, R. J. Ross, and A. R. Morrison. 2003. GABAergic regulation of REM sleep in reticularis pontis oralis and caudalis in rats. J Neurophysiol 90:938–945.PubMedGoogle Scholar
  294. Sarter, M., and J. P. Bruno. 2000. Cortical cholinergic inputs mediating arousal, attentional processing and dreaming: differential afferent regulation of the basal forebrain by telencephalic and brainstem afferents. Neuroscience 95:933–952.PubMedGoogle Scholar
  295. Schwierin, B., A. A. Borbely, and I. Tobler. 1996. Effects of N 6-cyclopentyladenosine and caffeine on sleep regulation in the rat. Eur J Pharmacol 300:163–171.PubMedGoogle Scholar
  296. Shafer, A. 1995. Metaphor and anesthesia. Anesthesiology 83:1331–1342.PubMedGoogle Scholar
  297. Shaw, I. R., G. Lavigne, P. Mayer, and M. Choinière. 2005. Acute intravenous administration of morphine perturbs sleep architecture in healthy pain-free young adults: a preliminary study. Sleep 28:677–682.PubMedGoogle Scholar
  298. Sherin, J. E., J. K. Elmquist, F. Torrealba, and C. B. Saper. 1998. Innervation of histaminergic tuberomamillary neurons by GABAergic and galaninergic neurons in the ventrolateral preoptic nucleus of the rat. J Neurosci 18:4705–4721.PubMedGoogle Scholar
  299. Sherin, J. E., P. J. Shiromani, R. W. McCarley, and C. B. Saper. 1996. Activation of ventrolateral preoptic neurons during sleep. Science 271:216–219.PubMedGoogle Scholar
  300. Shiromani, P. J., D. M. Armstrong, and J. C. Gillin. 1988. Cholinergic neurons from the dorsolateral pons project to the medial pons: a WGA-HRP and choline acetyltransferase immunohistochemical study. Neurosci Lett 95:19–23.PubMedGoogle Scholar
  301. Shou, M., C. R. Ferrario, K. N. Schultz, T. E. Robinson, and R. T. Kennedy. 2006. Monitoring dopamine in vivo by microdialysis sampling and on-line CE-laser-induced fluorescence. Anal Chem 78:6717–6725.PubMedGoogle Scholar
  302. Silber, M. H., S. Ancoli-Israel, M. H. Bonnet, S. Chokroverty, M. M. Grigg-Damberger, M. Hirshkowitz, S. Kapen, S. A. Keenan, M. H. Kryger, T. Penzel, M. R. Pressman, and C. Iber. 2007. The visual scoring of sleep in adults. J Clin Sleep Med 3:121–131.PubMedGoogle Scholar
  303. Silva, A. P., C. Cavadas, and E. Grouzmann. 2002. Neuropeptide Y and its receptors as potential therapeutic drug targets. Clin Chim Acta 326:3–25.PubMedGoogle Scholar
  304. Simon, H., M. Le Moal, L. Stinus, and A. Calas. 1979. Anatomical relationships between the ventral mesencephalic tegmentum-A10 region and the locus coeruleus as demonstrated by anterograde and retrograde tracing techniques. J Neural Transm 44:77–86.PubMedGoogle Scholar
  305. Sitaram, N., A. M. Moore, and J. C. Gillin. 1978. Experimental acceleration and slowing of REM sleep ultradian rhythm by cholinergic agonist and antagonist. Nature 274:490–492.PubMedGoogle Scholar
  306. Sitaram, N., R. J. Wyatt, S. Dawson, and J. C. Gillin. 1976. REM sleep induction by physostigmine infusion during sleep. Science 191:1281–1283.PubMedGoogle Scholar
  307. Smith, A., C. J. Watson, K. J. Frantz, B. Eppler, R. T. Kennedy, and J. Peris. 2004. Differential increase in taurine levels by low-dose ethanol in the dorsal and ventral striatum revealed by microdialysis with on-line capillary electrophoresis. Alcohol Clin Exp Res 28:1028–1038.PubMedGoogle Scholar
  308. Smith, M. T., and J. A. Haythornthwaite. 2004. How do sleep disturbance and chronic pain inter-relate? Insights from the longitudinal and cognitive-behavioral clinical trials literature. Sleep Med Rev 8:119–132.PubMedGoogle Scholar
  309. Soffin, E. M., C. H. Gill, S. J. Brough, J. C. Jerman, and C. H. Davies. 2004. Pharmacological characterization of the orexin receptor subtype mediating postsynaptic excitation in the rat dorsal raphé nucleus. Neuropharmacology 46:1168–1176.Google Scholar
  310. Sood, S., J. K. Dhawan, V. Ramesh, J. John, G. Gopinath, and V. M. Kumar. 1997. Role of medial preoptic area beta adrenoceptors in the regulation of sleep-wakefulness. Pharmacol Biochem Behav 57:1–5.PubMedGoogle Scholar
  311. Spiegel, K., E. Tasali, P. Penev, and E. Van Cauter. 2004. Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 141:846–850.PubMedGoogle Scholar
  312. Steinfels, G. F., J. Heym, R. E. Strecker, and B. L. Jacobs. 1983. Behavioral correlates of dopaminergic unit activity in freely moving cats. Brain Res 258:217–228.PubMedGoogle Scholar
  313. Steininger, T. L., M. N. Alam, H. Gong, R. Szymusiak, and D. J. McGinty. 1999. Sleep-waking discharge of neurons in the posterior lateral hypothalamus of the albino rat. Brain Res 840:138–147.PubMedGoogle Scholar
  314. Steininger, T. L., H. Gong, D. J. McGinty, and R. Szymusiak. 2001. Subregional organization of preoptic area/anterior hypothalamic projections to arousal-related monoaminergic cell groups. J Comp Neurol 429:638–653.PubMedGoogle Scholar
  315. Steriade, M., and R. W. McCarley, eds. 2005. Brain Control of Wakefulness and Sleep. New York: Kluwer Academic/Plenum Publishers.Google Scholar
  316. Steriade, M., G. Oakson, and N. Ropert. 1982. Firing rates and patterns of midbrain reticular neurons during steady and transitional states of the sleep-waking cycle. Exp Brain Res 46:37–51.PubMedGoogle Scholar
  317. Stevens, D. R., R. W. McCarley, and R. W. Greene. 1992. Excitatory amino acid-mediated responses and synaptic potentials in medial pontine reticular formation neurons of the rat in vitro. J Neurosci 12:4188–4194.PubMedGoogle Scholar
  318. Strecker, R. E., S. Moriarty, M. M. Thakkar, T. Porkka-Heiskanen, R. Basheer, L. J. Dauphin, D. G. Rainnie, C. M. Portas, R. W. Greene, and R. W. McCarley. 2000. Adenosinergic modulation of basal forebrain and preoptic/anterior hypothalamic neuronal activity in the control of behavioral state. Behav Brain Res 115:183–204.PubMedGoogle Scholar
  319. Suntsova, N., R. Szymusiak, M. N. Alam, R. Guzman-Marin, and D. J. McGinty. 2002. Sleep-waking discharge patterns of median preoptic nucleus neurons in rats. J Physiol 543:665–677.PubMedGoogle Scholar
  320. Sweet, C. P., and J. A. Hobson. 1968. The effects of posterior hypothalamic lesions on behavioral and electrographic manifestations of sleep and waking in cats. Arch Ital Biol 106:283–293.Google Scholar
  321. Szentirmai, E., L. Kapás, and J. M. Krueger. 2007. Ghrelin microinjection into forebrain sites induces wakefulness and feeding in rats. Am J Physiol Regul Integr Comp Physiol 292:R575–R585.PubMedGoogle Scholar
  322. Szentirmai, E., and J. M. Krueger. 2006. Central administration of neuropeptide Y induces wakefulness in rats. Am J Physiol Regul Integr Comp Physiol 291:R473–R480.PubMedGoogle Scholar
  323. Szymusiak, R., M. N. Alam, T. L. Steininger, and D. J. McGinty. 1998. Sleep-waking discharge patterns of ventrolateral preoptic/anterior hypothalamic neurons in rats. Brain Res 803:178–188.PubMedGoogle Scholar
  324. Szymusiak, R., and D. J. McGinty. 1986. Sleep-related neuronal discharge in the basal forebrain of cats. Brain Res 370:82–92.PubMedGoogle Scholar
  325. Taheri, S., L. Lin, D. Austin, T. Young, and E. Mignot. 2004. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med 1(e62):210–217.Google Scholar
  326. Taheri, S., M. Mahmoodi, J. Opacka-Juffry, M. A. Ghatei, and S. R. Bloom. 1999. Distribution and quantification of immunoreactive orexin A in rat tissues. FEBS Lett 457:157–161.PubMedGoogle Scholar
  327. Takahashi, K., Y. Koyama, Y. Kayama, and M. Yamamoto. 2002. Effects of orexin on the laterodorsal tegmental neurones. Psychiat Clin Neurosci 56:335–336.Google Scholar
  328. Takahashi, K., J. S. Lin, and K. Sakai. 2006. Neuronal activity of histaminergic tuberomammillary neurons during wake-sleep states in the mouse. J Neurosci 26:10292–10298.PubMedGoogle Scholar
  329. Takahashi, K., J. S. Lin, and K. Sakai. 2008. Neuronal activity of orexin and non-orexin waking-active neurons during wake-sleep states in the mouse. Neuroscience 153:860–870.PubMedGoogle Scholar
  330. Tanase, D., W. A. Martin, H. A. Baghdoyan, and R. Lydic. 2001. G protein activation in rat ponto-mesencephalic nuclei is enhanced by combined treatment with a mu opioid and an adenosine A1 receptor agonist. Sleep 24:1–11.Google Scholar
  331. Tao, R., Z. Ma, J. T. McKenna, M. Thakkar, S. Winston, R. E. Strecker, and R. W. McCarley. 2006. Differential effect of orexins (hypocretins) on serotonin release in the dorsal and median raphé nuclei of freely behaving rats. Neuroscience 141:1101–1105.PubMedGoogle Scholar
  332. Thakkar, M., C. Portas, and R. W. McCarley. 1996. Chronic low-amplitude electrical stimulation of the laterodorsal tegmental nucleus of freely moving cats increases REM sleep. Brain Res 723:223–227.PubMedGoogle Scholar
  333. Thakkar, M. M., V. Ramesh, E. G. Cape, S. Winston, R. E. Strecker, and R. W. McCarley. 1999. REM sleep enhancement and behavioral cataplexy following orexin (hypocretin)-II receptor antisense perfusion in the pontine reticular formation. Sleep Res Online 2:113–120.Google Scholar
  334. Thakkar, M. M., V. Ramesh, R. E. Strecker, and R. W. McCarley. 2001. Microdialysis perfusion of orexin-A in the basal forebrain increases wakefulness in freely behaving rat. Arch Ital Biol 139:313–328.PubMedGoogle Scholar
  335. Thakkar, M. M., R. E. Strecker, and R. W. McCarley. 1998. Behavioral state control through differential serotonergic inhibition in the mesopontine cholinergic nuclei: a simultaneous unit recording and microdialysis study. J Neurosci 18:5490–5497.PubMedGoogle Scholar
  336. Thakkar, M. M., S. C. Engemann, K. M. Walsh, and P. K. Sahota. 2008. Adenosine and the homeostatic control of sleep: effects of A1 receptor blockade in the perifornical lateral hypothalamus. Neuroscience 153:875–880.PubMedGoogle Scholar
  337. Thakkar, M. M., S. Winston, and R. W. McCarley. 2003. A1 receptor and adenosine homeostatic regulation of sleep-wakefulness: effects of antisense to the A1 receptor in the cholinergic basal forebrain. J Neurosci 23:4278–4287.PubMedGoogle Scholar
  338. Thakkar, M. M., S. Winston, and R. W. McCarley. 2008. Effect of microdialysis perfusion of 4,5,6,7-tetrahydroisoxazolo-[5,4-C]pyridine-3-ol in the perifornical hypothalamus on sleep-wakefulness: role of δ-subunit containing extrasynaptic GABAA receptors. Neuroscience 153:551–555.PubMedGoogle Scholar
  339. Thannickal, T. C., R. Y. Moore, R. Nienhuis, L. Ramanathan, S. Gulyani, M. Aldrich, M. Cornford, and J. M. Siegel. 2000. Reduced number of hypocretin neurons in human narcolepsy. Neuron 27:469–474.PubMedGoogle Scholar
  340. Ticho, S. R., and M. Radulovacki. 1991. Role of adenosine in sleep and temperature regulation in the preoptic area of rats. Pharmacol Biochem Behav 40:33–40.PubMedGoogle Scholar
  341. Tokunaga, S., Y. Takeda, K. Shinomiya, M. Hirase, and C. Kamei. 2007. Effects of some H1-antagonists on the sleep-wake cycle in sleep-disturbed rats. J Pharmacol Sci 103:201–206.PubMedGoogle Scholar
  342. Tose, R., T. Kushikata, H. Yoshida, M. Kudo, K. Furukawa, S. Ueno, and K. Hirota. 2009. Orexin A decreases ketamine-induced anesthesia time in the rat: the relevance to brain noradrenergic neuronal activity. Anesth Analg 108:491–495.PubMedGoogle Scholar
  343. Tóth, A., T. Hajnik, L. Záborszky, and L. Détári. 2007. Effect of basal forebrain neuropeptide Y administration on sleep and spontaneous behavior in freely moving rats. Brain Res Bull 72:293–301.PubMedGoogle Scholar
  344. Trescot, A. M., S. Datta, M. G. Lee, and H. Hansen. 2008. Opioid Pharmacology. Pain Physician 11:S133–S153.PubMedGoogle Scholar
  345. Trulson, M. E., and B. L. Jacobs. 1979. Raphé unit activity in freely moving cats: correlation with level of behavioral arousal. Brain Res 163:135–150.PubMedGoogle Scholar
  346. Tung, A., B. Bluhm, and W. B. Mendelson. 2001. Sleep inducing effects of propofol microinjection into the medial preoptic area are blocked by flumazenil. Brain Res 908:155–160.PubMedGoogle Scholar
  347. Urbain, N., K. Creamer, and G. Debonnel. 2006. Electrophysical diversity of the dorsal raphé cells across the sleep-wake cycle of the rat. J Physiol 573.3:679–695.Google Scholar
  348. Valldeoriola, F., J. Santamaria, F. Graus, and E. Tolosa. 1993. Absence of REM sleep, altered NREM sleep and supranuclear horizontal gaze palsy caused by a lesion of the pontine tegmentum. Sleep 16:184–188.PubMedGoogle Scholar
  349. Van Dort, C. J., H. A. Baghdoyan, and R. Lydic. 2008. Neurochemical modulators of sleep and anesthetic states. Int Anesthesiol Clin 46:75–104.PubMedGoogle Scholar
  350. Van Dort, C. J., H. A. Baghdoyan, and R. Lydic. 2009. Adenosine A1 and A2A receptors in mouse prefrontal cortex modulate acetylcholine release and behavioral arousal. J Neurosci 29:871–881.PubMedGoogle Scholar
  351. Vanini, G., P. Torterolo, R. McGregor, M. H. Chase, and F. R. Morales. 2007. GABAergic processes in the mesencephalic tegmentum modulate the occurrence of active (rapid eye movement) sleep in guinea pigs. Neuroscience 145:1157–1167.PubMedGoogle Scholar
  352. Vanini, G., C. J. Watson, R. Lydic, and H. A. Baghdoyan. 2008. γ-aminobutyric acid-mediated neurotransmission in the pontine reticular formation modulates hypnosis, immobility, and breathing during isoflurane anesthesia. Anesthesiology 109:978–988.PubMedGoogle Scholar
  353. Vanni-Mercier, G., K. Sakai, and M. Jouvet. 1984. Neurones spécifiques de l’éveil dans l’hypothalamus postérieur du chat. Comptes Rendus de l Acad des Sciences Serie III 298:195–200.Google Scholar
  354. Vazquez, J., and H. A. Baghdoyan. 2001. Basal forebrain acetylcholine release during REM sleep is significantly greater than during waking. Am J Physiol Regul Integr Comp Physiol 280:R598–R601.PubMedGoogle Scholar
  355. Virus, R. M., M. Djuricic-Nedelson, M. Radulovacki, and R. D. Green. 1983. The effects of adenosine and 2-deoxycoformycin on sleep and wakefulness in rats. Neuropharmacology 22:1401–1404.Google Scholar
  356. Vittoz, N. M., and C. W. Berridge. 2006. Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex: involvement of the ventral tegmental area. Neuropsychopharmacol 31:384–395.Google Scholar
  357. von Economo, C. V. 1930. Sleep as a problem of localization. J Nerv Ment Dis 72:249–259.Google Scholar
  358. Walker, E. A. 1998. Clinical and pathological examination of patients with neurological disorders. In The Genesis of Neuroscience, edited by E. R. Laws Jr. and G. B. Udvarhelyi. Park Ridge: AANS.Google Scholar
  359. Walsh, J. K., S. Deacon, D.-J. Dijk, and J. Lundahl. 2007. The selective extrasynaptic GABAA agonist, gaboxadol, improves traditional hypnotic efficacy measures and enhances slow wave activity in a model of transient insomnia. Sleep 30:593–602.PubMedGoogle Scholar
  360. Walsh, J. K., D. Mayleben, C. Guico-Pabia, K. Vandormael, R. Martinez, and S. Deacon. 2008. Efficacy of the selective extrasynaptic GABAA agonist, gaboxadol, in a model of transient insomnia: a randomized, controlled clinical trial. Sleep Med 9:393–402.PubMedGoogle Scholar
  361. Walsh, J. K., G. Zammit, P. K. Schweitzer, J. Ondrasik, and T. Roth. 2006. Tiagabine enhances slow wave sleep and sleep maintenance in primary insomnia. Sleep Med 7:155–161.PubMedGoogle Scholar
  362. Wang, M., G. T. Roman, K. Schultz, C. Jennings, and R. T. Kennedy. 2008. Improved temporal resolution for in vivo microdialysis by using segmented flow. Anal Chem 80:5607–5615.PubMedGoogle Scholar
  363. Wang, W., H. A. Baghdoyan, and R. Lydic. 2009. Leptin replacement restores supraspinal cholinergic antinociception in leptin deficient obese mice. J Pain 10:836–843.Google Scholar
  364. Watanabe, S., T. Kuwaki, M. Yanagisawa, Y. Fokuda, and M. Shimoyama. 2005. Persistent pain and stress activate pain-inhibitory orexin pathways. Neuroreport 16:5–8.PubMedGoogle Scholar
  365. Watanabe, T., Y. Taguchi, S. Shiosaka, J. Tanaka, H. Kubota, Y. Terano, M. Tohyama, and H. Wada. 1984. Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res 295:13–25.PubMedGoogle Scholar
  366. Watson, C. J., R. Lydic, and H. A. Baghdoyan. 2007. Sleep and GABA levels in the oral part of rat pontine reticular formation are decreased by local and systemic administration of morphine. Neuroscience 144:375–386.PubMedGoogle Scholar
  367. Watson, C. J., R. Lydic, and H. A. Baghdoyan. 2008. Pontine reticular formation (PnO) administration of hypocretin-1 increases PnO GABA levels and wakefulness. Sleep 31:453–464.PubMedGoogle Scholar
  368. Watson, C. J., B. J. Venton, and R. T. Kennedy. 2006. In vivo measurements of neurotransmitters using microdialysis sampling. Anal Chem 78:1391–1399.PubMedGoogle Scholar
  369. Webster, H. H., and B. E. Jones. 1988. Neurotoxic lesions of the dorsolateral pontomesencephalic tegmentum-cholinergic cell area in the cat. II. Effects upon sleep-waking states. Brain Res 458:285–302.PubMedGoogle Scholar
  370. Willie, J. T., R. M. Chemelli, C. M. Sinton, S. Tokita, S. C. Williams, Y. Y. Kisanuki, J. N. Marcus, C. Lee, J. K. Elmquist, K. A. Kohlmeier, C. S. Leonard, J. A. Richardson, R. E. Hammer, and M. Yanagisawa. 2003. Distinct narcolepsy syndromes in orexin receptor-2 and orexin null mice: molecular genetic dissection of non-REM and REM sleep regulatory processes. Neuron 38:715–730.PubMedGoogle Scholar
  371. Wilson, S. J., J. E. Bailey, A. S. Rich, J. Nash, M. Adrover, A. Tournoux, and D. J. Nutt. 2005. The use of sleep measures to compare a new 5HT1A agonist with buspirone in humans. J Psychopharmacol 19:609–613.PubMedGoogle Scholar
  372. Winsky-Sommerer, R., V. V. Vyazovskiy, G. E. Homanics, and I. Tobler. 2007. The EEG effects of THIP (gaboxadol) on sleep and waking are mediated by the GABAA δ-subunit-containing receptors. Eur J Neurosci 25:1893–1899.PubMedGoogle Scholar
  373. Wisor, J. P., S. Nishino, I. Sora, G. H. Uhl, E. Mignot, and D. M. Edgar. 2001. Dopaminergic role in stimulant-induced wakefulness. J Neurosci 21:1787–1794.PubMedGoogle Scholar
  374. Woodbridge, P. D. 1957. Changing concepts concerning depth of anesthesia. Anesthesiology 18:536–550.PubMedGoogle Scholar
  375. Woolf, N. J., and L. L. Butcher. 1986. Cholinergic systems in the rat brain: III. Projections from the pontomesencephalic tegmentum to the thalamus, tectum, basal ganglia, and basal forebrain. Brain Res Bull 16:603–637.PubMedGoogle Scholar
  376. Woolf, N. J., and L. L. Butcher. 1989. Cholinergic systems in the rat brain: IV. Descending projections of the pontomesencephalic tegmentum. Brain Res Bull 23:519–540.PubMedGoogle Scholar
  377. Woolf, N. J., F. Eckenstein, and L. L. Butcher. 1984. Cholinergic systems in the rat brain: I. Projections to the limbic telencephalon. Brain Res Bull 13:751–784.PubMedGoogle Scholar
  378. Xi, M.-C., and M. H. Chase. 2008. Effects of eszopiclone and zolpidem on sleep and waking states in the adult guinea pig. Sleep 31:1043–1051.PubMedGoogle Scholar
  379. Xi, M.-C., S. J. Fung, J. Yamuy, F. R. Morales, and M. H. Chase. 2002. Induction of active (REM) sleep and motor inhibition by hypocretin in the nucleus pontis oralis of cat. J Neurophysiol 87:2880–2888.PubMedGoogle Scholar
  380. Xi, M.-C., F. R. Morales, and M. H. Chase. 1999. Evidence that wakefulness and REM sleep are controlled by a GABAergic pontine mechanism. J Neurophysiol 82:2015–2019.PubMedGoogle Scholar
  381. Xi, M.-C., F. R. Morales, and M. H. Chase. 2001. Effects on sleep and wakefulness of the injection of hypocretin-1 (orexin-A) into the laterodorsal tegmental nucleus of the cat. Brain Res 901:259–264.PubMedGoogle Scholar
  382. Xu, Y.-L., R. K. Reinscheid, S. Huitron-Resendiz, S. D. Clark, Z. Wang, S. H. Lin, F. A. Brucher, J. Zeng, N. K. Ly, S. J. Henriksen, L. de Lecea, and O. Civelli. 2004. Neuropeptide S: a neuropeptide promoting arousal and anxiolytic effects. Neuron 43:487–497.PubMedGoogle Scholar
  383. Yamamoto, T., N. Nozaki-Taguchi, and T. Chiba. 2002. Analgesic effect of intrathecally administered orexin-A in the rat formalin test and in the rat hot plate test. Br J Pharmacol 137:170–176.PubMedGoogle Scholar
  384. Zaborszky, L., B. E. Cullinan, and A. Braun. 1991. Afferents to basal forebrain cholinergic neurons: an update. Adv Exp Med Biol 295:43–100.PubMedGoogle Scholar
  385. Zhang, G., L. Wang, H. Liu, and J. Zhang. 2004. Substance P promotes sleep in the ventrolateral preoptic area of rats. Brain Res 1028:225–232.PubMedGoogle Scholar
  386. Zhang, J.-H., S. Sampogna, F. R. Morales, and M. H. Chase. 2004. Distribution of hypocretin (orexin) immunoreactivity in the feline pons and medulla. Brain Res 995:205–217.PubMedGoogle Scholar

Copyright information

© Humana Press, a part of Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Christopher J. Watson
    • 1
  • Helen A. Baghdoyan
    • 1
  • Ralph Lydic
    • 1
  1. 1.Department of AnesthesiologyUniversity of MichiganAnn ArborUSA

Personalised recommendations